DT
BIO icon

Diversified Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Diversified Trust’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$978K Sell
3,332
-1,565
-32% -$444K 0.02% 511
2026
Q1 		$1.37M Sell
4,897
-3,237
-40% -$932K 0.03% 352
2025
Q4 		$2.46M Buy
8,134
+3
+0% +$936 0.05% 222
2025
Q3 		$2.28M Buy
8,131
+22
+0.3% +$5.99K 0.05% 228
2025
Q2 		$1.96M Buy
8,109
+23
+0.3% +$5.44K 0.04% 240
2025
Q1 		$1.97M Buy
8,086
+5,170
+177% +$1.56M 0.05% 213
2024
Q4 		$958K Buy
+2,916
New +$990K 0.02% 377
2024
Q2 		– Sell
-5,957
Closed -$2.06M – 885
2024
Q1 		$2.06M Buy
5,957
+4,299
+259% +$1.41M 0.06% 187
2023
Q4 		$535K Buy
1,658
+143
+9% +$44.8K 0.02% 484
2023
Q3 		$543K Sell
1,515
-1,049
-41% -$405K 0.02% 436
2023
Q2 		$972K Sell
2,564
-23
-0.9% -$9.36K 0.04% 284
2023
Q1 		$1.24M Sell
2,587
-893
-26% -$418K 0.05% 217
2022
Q4 		$1.46M Sell
3,480
-330
-9% -$133K 0.06% 172
2022
Q3 		$1.59M Buy
3,810
+302
+9% +$151K 0.07% 137
2022
Q2 		$1.74M Buy
3,508
+235
+7% +$122K 0.07% 137
2022
Q1 		$1.84M Buy
3,273
+859
+36% +$518K 0.06% 150
2021
Q4 		$1.82M Buy
2,414
+87
+4% +$65.1K 0.06% 157
2021
Q3 		$1.74M Sell
2,327
-145
-6% -$109K 0.06% 154
2021
Q2 		$1.59M Buy
2,472
+414
+20% +$252K 0.06% 159
2021
Q1 		$1.18M Buy
2,058
+702
+52% +$416K 0.05% 192
2020
Q4 		$790K Buy
1,356
+212
+19% +$121K 0.03% 247
2020
Q3 		$590K Buy
1,144
+35
+3% +$17.7K 0.03% 273
2020
Q2 		$501K Buy
+1,109
New +$489K 0.03% 255
2014
Q2 		$946K Buy
+7,905
New +$965K 0.08% 263
2013
Q4 		$1.18M Hold
9,525
– – 0.12% 170
2013
Q3 		$1.12M Buy
9,525
+60
+0.6% +$7.08K 0.12% 183
2013
Q2 		$1.06M Buy
+9,465
New +$1.11M 0.13% 166

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Diversified Trust's BIO Position: Q2 2026 in Review

Diversified Trust reduced its Bio-Rad Laboratories Class A (BIO) stake by 32% in Q2 2026, selling an estimated $444K and leaving 3,332 shares worth $978K. The position accounts for 0.02% of the portfolio, ranked #511.

Diversified Trust first reported a position in BIO in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.46M in Q4 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Diversified Trust held 3,332 shares of Bio-Rad Laboratories Class A worth $978K as of Q2 2026.
  • Diversified Trust sold 1,565 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $444K.
  • Bio-Rad Laboratories Class A made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #511 holding.
  • Diversified Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 27 quarters since.
  • Diversified Trust's Bio-Rad Laboratories Class A position peaked at $2.46M in Q4 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.